| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.95B | 22.46B | 20.41B | 17.95B | 16.28B | 14.92B |
| Gross Profit | 15.64B | 15.42B | 14.22B | 12.43B | 11.25B | 10.50B |
| EBITDA | 3.58B | 3.78B | 3.56B | 2.79B | 2.45B | 2.40B |
| Net Income | 2.07B | 2.24B | 2.15B | 1.65B | 1.94B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 34.81B | 35.37B | 31.56B | 29.06B | 26.61B | 24.94B |
| Cash, Cash Equivalents and Short-Term Investments | 14.66B | 16.40B | 15.26B | 12.80B | 12.38B | 10.73B |
| Total Debt | 1.12B | 1.25B | 74.03M | 56.11M | 78.70M | 1.04B |
| Total Liabilities | 10.26B | 9.82B | 7.93B | 6.93B | 5.81B | 7.12B |
| Stockholders Equity | 23.00B | 23.97B | 22.31B | 21.03B | 19.85B | 17.44B |
Cash Flow | ||||||
| Free Cash Flow | 501.92M | 1.92B | 2.59B | 1.67B | 728.46M | 1.93B |
| Operating Cash Flow | 587.25M | 2.68B | 2.97B | 1.94B | 1.15B | 2.68B |
| Investing Cash Flow | 561.05M | -1.89B | -882.83M | -551.14M | 1.08B | -887.11M |
| Financing Cash Flow | -350.69M | 552.58M | -998.18M | -500.49M | -76.00M | 109.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥35.42B | 20.67 | 8.89% | 2.59% | 10.25% | -9.38% | |
76 Outperform | ¥127.48B | 21.86 | 12.54% | 1.84% | 13.86% | 51.05% | |
72 Outperform | ¥862.40B | 16.97 | 6.61% | 1.58% | 5.02% | -27.41% | |
72 Outperform | ¥73.12B | 11.99 | 16.37% | 2.79% | 31.48% | 16.11% | |
68 Neutral | ¥681.68B | 23.01 | ― | 1.43% | 7.87% | 38.32% | |
66 Neutral | ¥174.43B | -49.70 | ― | 2.41% | 2.47% | 1.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |